ASH vs RSNA for Exhibitors
Side-by-side data and our editorial take on which conference is the right exhibit investment for your medical device.
By Buzzbox Media · Last reviewed August 3, 2026
If you exhibit medical devices, ASH and RSNA are likely both on your shortlist. Both serve overlapping clinical buyers, but the audience composition, booth economics, and exhibit floor experience differ in ways that materially affect ROI. ASH draws 27,000 attendees with no booth pricing published by the organizer. RSNA draws 38,000 attendees with no booth pricing published by the organizer. Below is the side-by-side data plus our editorial take on which conference fits which kind of exhibitor.
| 9.6 ASH | 10.0 RSNA | |
|---|---|---|
| Score | ||
| Buzzbox Score | 9.6 (Exceptional) | 10.0 (Exceptional) |
| Event Details | ||
| Dates | December 12-15, 2026 | November 29 - December 3, 2026 |
| Location | Ernest N. Morial Convention Center, New Orleans, LA | Chicago, IL (McCormick Place) |
| Scale | mega | mega |
| Audience | ||
| Attendees | 27,000 | 38,000 |
| Exhibitors | 275 | 650 |
| Purchasing authority, Buzzbox Media estimate | ~35% | ~78% |
| Effective buyers, Buzzbox Media estimate | 9,450 | 29,640 |
| Costs | ||
| $/sqft | n/a | $41.25 |
| 10×10 space | n/a | $4,125 |
| All-in, Buzzbox Media estimate | n/a | n/a |
| Cost per buyer, Buzzbox Media estimate | n/a | n/a |
Why exhibit at ASH
The world's largest hematology meeting: 27,000 attendees from 110+ countries. Late-breaking clinical trial data makes this the single most important event for hematology drug and diagnostic launches. If you sell flow cytometers, coagulation analyzers, cell/gene therapy products, or molecular diagnostics for blood disorders, ASH is the anchor show of your annual conference calendar.
Why exhibit at RSNA
Largest radiology gathering in the world. Essential for imaging equipment, contrast media, AI/digital health in radiology, and radiation protection vendors. Decision-makers come to see and touch new tech.
Why skip ASH
Booth pricing is opaque and expensive (pharma dominates with massive booths). The audience is heavily academic and research-oriented, so pure diagnostic device companies may find more actionable buyers at CAP (pathology) or AABB (blood banking). December in New Orleans also means holiday scheduling conflicts for booth staff and potential weather disruptions.
Why skip RSNA
Wrong audience for non-imaging device companies. Booth costs are brutal for first-timers.
ASH publishes no booth pricing we can link to, so no cost is listed for it. See the official ASH site ↗ for exhibitor details. RSNA booth figures are estimates read from its published exhibitor prospectus ↗, not quotes. Confirm current pricing with each organizer before committing a budget.
Frequently Asked Questions
Does ASH or RSNA have more decision makers?
RSNA does, on a Buzzbox Media estimate: roughly 29,640 effective buyers against about 9,450 at ASH. Effective buyers multiplies total attendance by the share of attendees who hold purchasing authority, so RSNA works out to about 38,000 attendees at roughly 78% authority, and ASH to about 27,000 at roughly 35%. Both inputs are estimates drawn from organizer reporting and our own exhibitor research, so read the gap as directional rather than exact.
Want to add a third conference to this comparison?
Compare these conferences in our interactive tool →Other conferences you might consider
Buzzbox Media is a healthcare marketing agency with over 15 years in medtech. See our conference marketing.